INS and COVID-19: In our CKD population, a higher risk of hospitalization due to COVID-19 was observed in patients prescribed insulin (aOR 1.36, 95% CI 1.12–1.64), proton pump inhibitors (PPI) (aOR 1.32, 95% CI 1.13–1.51), diuretics (aOR 1.29, 95% CI 1.01–1.37), corticosteroids (aOR 1.32, 95% CI 1.11–1.56) or other immunosuppressants (aOR 1.49, 95% CI 1.20–1.85) (Table 4).